- Filed
- May 7, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · Apr 23, 2026 | 239.75M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 199M sh |
| Shares Diluted restated | Q1 2026 · Mar 31, 2025 | 115M sh |
| Dividends Paid | Q1 2026 · Mar 31, 2026 | $82M |
| Dividends Paid restated | Q1 2026 · Mar 31, 2025 | $23M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | $640M |
| Operating Cash Flow restated | Q1 2026 · Mar 31, 2025 | $483M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $449M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $368M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $6.87B |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $4.81B |
| Stockholders Equity restated | Q1 2026 · Mar 31, 2025 | $4.4B |
| Stockholders Equity restated | Q1 2026 · Dec 31, 2024 | $4.24B |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $4.28B |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $1.17B |
| Current Assets | Q1 2026 · Mar 31, 2026 | $1.67B |
| Current Assets | Q1 2026 · Dec 31, 2025 | $811M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $19.14B |
| Total Assets | Q1 2026 · Dec 31, 2025 | $9.25B |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$1.68 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | $1.59 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$1.68 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | $1.59 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $174M |
| Sga Expense restated | Q1 2026 · Mar 31, 2025 | $39M |
| Net Income | Q1 2026 · Mar 31, 2026 | −$335M |
| Net Income restated | Q1 2026 · Mar 31, 2025 | $182M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$298M |
| Operating Income restated | Q1 2026 · Mar 31, 2025 | $276M |
| Revenue | Q1 2026 · Mar 31, 2026 | $1.48B |
| Revenue restated | Q1 2026 · Mar 31, 2025 | $845M |